Rapid Micro Biosystems (NASDAQ:RPID) Posts Earnings Results

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.22) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.22), Zacks reports. The company had revenue of $8.22 million during the quarter, compared to the consensus estimate of $8.20 million. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Price Performance

NASDAQ:RPID traded down $0.46 during mid-day trading on Monday, hitting $2.59. 938,421 shares of the company's stock were exchanged, compared to its average volume of 649,985. The company has a market cap of $111.46 million, a PE ratio of -2.31 and a beta of 1.26. Rapid Micro Biosystems has a one year low of $0.58 and a one year high of $4.04. The business has a fifty day moving average price of $1.95 and a 200 day moving average price of $1.31.

Wall Street Analysts Forecast Growth

Separately, KeyCorp assumed coverage on Rapid Micro Biosystems in a research report on Wednesday, February 12th. They issued an "overweight" rating and a $8.00 target price for the company.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.